Literature DB >> 28185868

Dengue: knowledge gaps, unmet needs, and research priorities.

Leah C Katzelnick1, Josefina Coloma1, Eva Harris2.   

Abstract

Dengue virus is a mosquito-borne pathogen that causes up to about 100 million cases of disease each year, placing a major public health, social, and economic burden on numerous low-income and middle-income countries. Major advances by investigators, vaccine developers, and affected communities are revealing new insights and enabling novel interventions and approaches to dengue prevention and control. Such research has highlighted further questions about both the basic understanding of dengue and efforts to develop new tools. In this report, the third in a Series on dengue, we discuss existing approaches to dengue diagnostics, disease prognosis, surveillance, and vector control in low-income and middle-income countries, as well as potential consequences of vaccine introduction. We also summarise current knowledge and recent insights into dengue epidemiology, immunology, and pathogenesis, and their implications for understanding natural infection and current and future vaccines.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28185868      PMCID: PMC5967882          DOI: 10.1016/S1473-3099(16)30473-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  144 in total

1.  Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies.

Authors:  Laurent Coudeville; Nicolas Baurin; Elisabeta Vergu
Journal:  Vaccine       Date:  2015-11-21       Impact factor: 3.641

2.  Melanotaenia duboulayi influence oviposition site selection by Culex annulirostris (Diptera: Culicidae) and Aedes notoscriptus (Diptera: Culicidae) but not Culex quinquefasciatus (Diptera: Culicidae).

Authors:  Timothy P Hurst; Brian H Kay; Michael D Brown; Peter A Ryan
Journal:  Environ Entomol       Date:  2010-04       Impact factor: 2.377

3.  Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever.

Authors:  Tadeusz J Kochel; Douglas M Watts; Scott B Halstead; Curtis G Hayes; Angelica Espinoza; Vidal Felices; Roxana Caceda; Christian T Bautista; Ysabel Montoya; Susan Douglas; Kevin L Russell
Journal:  Lancet       Date:  2002-07-27       Impact factor: 79.321

4.  Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.

Authors:  Maria Rosario Capeding; Ngoc Huu Tran; Sri Rezeki S Hadinegoro; Hussain Imam H J Muhammad Ismail; Tawee Chotpitayasunondh; Mary Noreen Chua; Chan Quang Luong; Kusnandi Rusmil; Dewa Nyoman Wirawan; Revathy Nallusamy; Punnee Pitisuttithum; Usa Thisyakorn; In-Kyu Yoon; Diane van der Vliet; Edith Langevin; Thelma Laot; Yanee Hutagalung; Carina Frago; Mark Boaz; T Anh Wartel; Nadia G Tornieporth; Melanie Saville; Alain Bouckenooghe
Journal:  Lancet       Date:  2014-07-10       Impact factor: 79.321

Review 5.  Identifying protective dengue vaccines: guide to mastering an empirical process.

Authors:  Scott B Halstead
Journal:  Vaccine       Date:  2013-07-26       Impact factor: 3.641

6.  Serotype-specific differences in clinical manifestations of dengue.

Authors:  Angel Balmaseda; Samantha N Hammond; Leonel Pérez; Yolanda Tellez; Saira Indira Saborío; Juan Carlos Mercado; Ricardo Cuadra; Julio Rocha; Maria Angeles Pérez; Sheyla Silva; Crisanta Rocha; Eva Harris
Journal:  Am J Trop Med Hyg       Date:  2006-03       Impact factor: 2.345

7.  Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans.

Authors:  Andreas Puschnik; Louis Lau; Elizabeth A Cromwell; Angel Balmaseda; Simona Zompi; Eva Harris
Journal:  PLoS Negl Trop Dis       Date:  2013-06-13

Review 8.  Biomarkers of severe dengue disease - a review.

Authors:  Daisy Vanitha John; Yee-Shin Lin; Guey Chuen Perng
Journal:  J Biomed Sci       Date:  2015-10-14       Impact factor: 8.410

9.  Community-based control of Aedes aegypti by adoption of eco-health methods in Chennai City, India.

Authors:  Natarajan Arunachalam; Brij Kishore Tyagi; Miriam Samuel; R Krishnamoorthi; R Manavalan; Satish Chandra Tewari; V Ashokkumar; Axel Kroeger; Johannes Sommerfeld; Max Petzold
Journal:  Pathog Glob Health       Date:  2012-12       Impact factor: 2.894

10.  The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.

Authors:  Laura A VanBlargan; Swati Mukherjee; Kimberly A Dowd; Anna P Durbin; Stephen S Whitehead; Theodore C Pierson
Journal:  PLoS Pathog       Date:  2013-12-05       Impact factor: 6.823

View more
  66 in total

1.  Antibody-based assay discriminates Zika virus infection from other flaviviruses.

Authors:  Angel Balmaseda; Karin Stettler; Raquel Medialdea-Carrera; Damaris Collado; Xia Jin; José Victor Zambrana; Stefano Jaconi; Elisabetta Cameroni; Saira Saborio; Francesca Rovida; Elena Percivalle; Samreen Ijaz; Steve Dicks; Ines Ushiro-Lumb; Luisa Barzon; Patricia Siqueira; David W G Brown; Fausto Baldanti; Richard Tedder; Maria Zambon; A M Bispo de Filippis; Eva Harris; Davide Corti
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

2.  Distinctive regulatory properties of pyruvate kinase 1 from Aedes aegypti mosquitoes.

Authors:  Natthida Petchampai; Claribel Murillo-Solano; Jun Isoe; Juan C Pizarro; Patricia Y Scaraffia
Journal:  Insect Biochem Mol Biol       Date:  2018-12-19       Impact factor: 4.714

Review 3.  Purinergic receptors and neglected tropical diseases: why ignore purinergic signaling in the search for new molecular targets?

Authors:  P A F Pacheco; L P Dantas; L G B Ferreira; Robson Xavier Faria
Journal:  J Bioenerg Biomembr       Date:  2018-06-07       Impact factor: 2.945

Review 4.  Humanized mouse models to study human cell-mediated and humoral responses to dengue virus.

Authors:  Anuja Mathew
Journal:  Curr Opin Virol       Date:  2017-08-09       Impact factor: 7.090

5.  Development and Performance of Dengue Diagnostic Clinical Algorithms in Colombia.

Authors:  Diana María Caicedo-Borrero; José Rafael Tovar; Andrés Méndez; Beatriz Parra; Anilza Bonelo; Jairo Celis; Liliana Villegas; Constanza Collazos; Lyda Osorio
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

Review 6.  Zika virus vaccines: immune response, current status, and future challenges.

Authors:  Justin M Richner; Michael S Diamond
Journal:  Curr Opin Immunol       Date:  2018-05-10       Impact factor: 7.486

7.  Dengue Virus Induces Increased Activity of the Complement Alternative Pathway in Infected Cells.

Authors:  Sheila Cabezas; Gustavo Bracho; Amanda L Aloia; Penelope J Adamson; Claudine S Bonder; Justine R Smith; David L Gordon; Jillian M Carr
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

8.  Immune correlates of protection for dengue: State of the art and research agenda.

Authors:  Leah C Katzelnick; Eva Harris
Journal:  Vaccine       Date:  2017-07-28       Impact factor: 3.641

9.  Nodosome Inhibition as a Novel Broad-Spectrum Antiviral Strategy against Arboviruses, Enteroviruses, and SARS-CoV-2.

Authors:  Daniel Limonta; Lovely Dyna-Dagman; William Branton; Valeria Mancinelli; Tadashi Makio; Richard W Wozniak; Christopher Power; Tom C Hobman
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

10.  Susceptible host availability modulates climate effects on dengue dynamics.

Authors:  Nicole Nova; Ethan R Deyle; Marta S Shocket; Andrew J MacDonald; Marissa L Childs; Martin Rypdal; George Sugihara; Erin A Mordecai
Journal:  Ecol Lett       Date:  2020-12-10       Impact factor: 9.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.